Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN109535037B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Ru-catalyzed method for symmetric ureas offers mild conditions and high selectivity, reducing manufacturing costs for pharmaceutical intermediates.